Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FNS007 in moderate-to-severe rheumatoid arthritis
CTR20253254Phase 2Active
- Sponsor
- Hebei Phoenix Biotechnology
- Start
- Sep 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of FNS007 in rheumatoid arthritis (RA), sponsored by Hebei Phoenix Biotechnology. Started Sep 2025; status: active.
02
Drugs
FNS007
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20253254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253254.